Comparing OneMedNet (NASDAQ:ONMD) & Medpace (NASDAQ:MEDP)

OneMedNet (NASDAQ:ONMD) and Medpace (NASDAQ:MEDP) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, dividends, earnings and risk.

Earnings & Valuation

This table compares OneMedNet and Medpace’s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OneMedNet	$1.02 million	15.23	-$23.20 million	($0.19)	-3.43
Medpace	$1.89 billion	6.33	$282.81 million	$8.88	43.36

Medpace has higher revenue and earnings than OneMedNet. OneMedNet is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares OneMedNet and Medpace’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
OneMedNet	N/A	N/A	-116.74%
Medpace	15.00%	63.98%	19.02%

Volatility & Risk

OneMedNet has a beta of -0.55, indicating that its share price is 155% less volatile than the S&P 500. Comparatively, Medpace has a beta of 1.38, indicating that its share price is 38% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent recommendations and price targets for OneMedNet and Medpace, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OneMedNet	0	0	0	0	N/A
Medpace	0	1	3	0	2.75

Medpace has a consensus target price of $382.00, suggesting a potential downside of 0.79%. Given Medpace’s higher probable upside, analysts clearly believe Medpace is more favorable than OneMedNet.

Insider and Institutional Ownership

1.0% of OneMedNet shares are held by institutional investors. Comparatively, 78.0% of Medpace shares are held by institutional investors. 45.7% of OneMedNet shares are held by company insiders. Comparatively, 20.3% of Medpace shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Medpace beats OneMedNet on 11 of the 13 factors compared between the two stocks.

About OneMedNet

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. The company is based in Eden Prairie, Minnesota.

About Medpace

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.